Importantly, this regulation seems to be present in prostate cancer patients, as we have observed a very strong correlation (p-value below 0.0001) between SOD2 and GLUT-1 protein in prostate cancer samples from patients, indicating that wherever SOD2 is high, so is GLUT-1. The gene discussed is SLC2A1; the disease is prostate carcinoma.